Results 321 to 330 of about 3,364,352 (377)

The Consequences of the Kennedy v. Braidwood Supreme Court Ruling on Fall Prevention

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Geoffrey J. Hoffman, A. Mark Fendrick
wiley   +1 more source

The future of neuromuscular blocking agents

Current Opinion in Anaesthesiology, 2020
Purpose of review The present review provides a summary of the literature on recent development of new neuromuscular blocking agents and presents clinically well established and new reversal agents. Recent findings Anesthesiologists are still waiting for the ideal neuromuscular ...
Christiane G. Stäuble, Manfred Blobner
openaire   +4 more sources

Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part II: New and novel agents

Muscle and Nerve, 2020
While traditional immunosuppressive and immunomodulatory therapies remain the cornerstone of immune‐mediated neuromuscular disease management, new and novel agents including antigen‐specific, monoclonal antibody drugs, have emerged as important treatment
C. Farmakidis   +3 more
semanticscholar   +1 more source

NEUROMUSCULAR BLOCKING AGENTS

International Anesthesiology Clinics, 1988
Clearly, many aspects of the action of neuromuscular blockers remain poorly understood at the molecular level. In the case of competitive blockers, blockade of EPPs by competitive binding to the ACh receptor site accounts for the most clinically important aspect of blockade.
Joe Henry Steinbach   +1 more
openaire   +3 more sources

Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012

Allergy. European Journal of Allergy and Clinical Immunology, 2018
Perioperative anaphylaxis mainly involves neuromuscular blocking agents (NMBAs) with an IgE‐mediated mechanism. In France, this life‐threatening condition is reported by anesthetists and allergologists, and two safety alerts concerning suxamethonium were
N. Petitpain   +35 more
semanticscholar   +1 more source

Neuromuscular blocking agents and reversal agents

Anaesthesia & Intensive Care Medicine, 2011
Abstract The neuromuscular junction consists of the motor nerve terminal, the synaptic cleft and post-synaptic nicotinic receptors on the motor end-plate of striated muscle. Neuromuscular blocking drugs are categorized into depolarizing and non-depolarizing agents.
Khorat Farooq   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy